title: Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis.
authors.affiliation: The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, M6 8HD, U.K.. amy.foulkes@manchester.ac.uk.
authors.forename: A C
authors.initials: AC
authors.lastname: Foulkes
authors.forename: L
authors.initials: L
authors.lastname: Wheeler
authors.forename: D
authors.initials: D
authors.lastname: Gosal
authors.forename: C E M
authors.initials: CE
authors.lastname: Griffiths
authors.forename: R B
authors.initials: RB
authors.lastname: Warren
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab